翻訳と辞書 |
Semuloparin sodium : ウィキペディア英語版 | Semuloparin sodium
Semuloparin (INN, USAN) is an experimental antithrombotic being developed by Sanofi-Aventis and belongs to the group of low molecular weight heparins (LMWH). It has completed Phase III clinical trials for the prevention of thromboembolism following various kinds of surgery such as hip replacement, as well as for patients undergoing chemotherapy. Like bemiparin, semuloparin is classified as an ultra-LMWH because of its low molecular mass of 2000–3000 Daltons on average. (Enoxaparin has 4500 Daltons.) These heparins have lower anti-thrombin activity than classical LMWHs and act mainly on factor Xa, reducing the risk of bleeding.〔(Statement On A Nonproprietary Name Adopted By The Usan Council: Semuloparin Sodium )〕 ==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Semuloparin sodium」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|